动脉粥样硬化患者颈动脉内膜中层厚度与血浆溶血磷脂酸含量的变化

[1] Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Rother E,Brandl R,Baker DL,et al. Circulation . 2003

[2] Plaque rupture, lysophosphatidic acid, and thrombosis. Spector AA. Circulation . 2003

[3] Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Siess W,Zangl KJ,Essler M,et al. Proceedings of the National Academy of Sciences of the United States of America . 1999

[4] Common carotid intimamedia thickness and risk of stroke and myocardial infarction: the Rotterdam study. Bots ML,Hoes AW,Koudstaal PJ,et al. Circulation . 1997

[5] Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. Takiuchi S,Kamide K,Miwa Y et al. Journal of Human Hypertension . 2004

[6] Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Siess W. Biochimica et Biophysica Acta . 2002

[1] Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Rother E,Brandl R,Baker DL,et al. Circulation . 2003

[2] Plaque rupture, lysophosphatidic acid, and thrombosis. Spector AA. Circulation . 2003

[3] Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Siess W,Zangl KJ,Essler M,et al. Proceedings of the National Academy of Sciences of the United States of America . 1999

[4] Common carotid intimamedia thickness and risk of stroke and myocardial infarction: the Rotterdam study. Bots ML,Hoes AW,Koudstaal PJ,et al. Circulation . 1997

[5] Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. Takiuchi S,Kamide K,Miwa Y et al. Journal of Human Hypertension . 2004

[6] Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Siess W. Biochimica et Biophysica Acta . 2002